Clinical Trial Update: Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study assessing intrapleural bevacizumab after pleural drainage in patients with malignant pleural effusion due to breast cancer; the trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Malignant Pleural Effusion

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Institut Curie | Conditions: Pleural Effusion, Malignant, Breast Cancer | Phase 1 | Status: TERMINATED